Literature DB >> 19895576

Alanine aminotransferase of Trypanosoma brucei--a key role in proline metabolism in procyclic life forms.

Diana Spitznagel1, Charles Ebikeme, Marc Biran, Nóirín Nic a' Bháird, Frédéric Bringaud, Gary T M Henehan, Derek P Nolan.   

Abstract

African trypanosomes possess high levels of alanine aminotransferase (EC 2.6.1.2), although the function of their activity remains enigmatic, especially in slender bloodstream forms where the metabolism of ketoacids does not occur. Therefore, the gene for alanine aminotransferase enzyme in Trypanosoma brucei (TbAAT) was characterized and its function assessed using a combination of RNA interference and gene knockout approaches. Surprisingly, as much as 95% or more of the activity appears to be unnecessary for growth of either bloodstream or procyclic forms respiring on glucose. A combination of RNA interference and NMR spectroscopy revealed an important role for the activity in procyclic forms respiring on proline. Under these conditions, the major end product of proline metabolism is alanine, and a reduction in TbAAT activity led to a proportionate decrease in the amount of alanine excreted along with an increase in the doubling time of the cells. These results provide evidence of a role for alanine aminotransferase in the metabolism of proline in African trypanosomes by linking glutamate produced by the initial oxidative steps of the pathway with pyruvate produced by the final oxidative step of the pathway. This step appears to be essential when proline is the primary carbon source, which is likely to be the physiological situation in the tsetse fly vector.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895576     DOI: 10.1111/j.1742-4658.2009.07432.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

1.  ATP synthesis-coupled and -uncoupled acetate production from acetyl-CoA by mitochondrial acetate:succinate CoA-transferase and acetyl-CoA thioesterase in Trypanosoma.

Authors:  Yoann Millerioux; Pauline Morand; Marc Biran; Muriel Mazet; Patrick Moreau; Marion Wargnies; Charles Ebikeme; Kamel Deramchia; Lara Gales; Jean-Charles Portais; Michael Boshart; Jean-Michel Franconi; Frédéric Bringaud
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

2.  Trypanosoma brucei metabolite indolepyruvate decreases HIF-1α and glycolysis in macrophages as a mechanism of innate immune evasion.

Authors:  Anne F McGettrick; Sarah E Corcoran; Paul J G Barry; Jennifer McFarland; Cécile Crès; Anne M Curtis; Edward Franklin; Sinéad C Corr; K Hun Mok; Eoin P Cummins; Cormac T Taylor; Luke A J O'Neill; Derek P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-15       Impact factor: 11.205

3.  Divergence of Erv1-associated mitochondrial import and export pathways in trypanosomes and anaerobic protists.

Authors:  Somsuvro Basu; Joanne C Leonard; Nishal Desai; Despoina A I Mavridou; Kong Ho Tang; Alan D Goddard; Michael L Ginger; Julius Lukeš; James W A Allen
Journal:  Eukaryot Cell       Date:  2012-12-21

4.  Procyclic trypanosomes recycle glucose catabolites and TCA cycle intermediates to stimulate growth in the presence of physiological amounts of proline.

Authors:  Oriana Villafraz; Marc Biran; Erika Pineda; Nicolas Plazolles; Edern Cahoreau; Rodolpho Ornitz Oliveira Souza; Magali Thonnus; Stefan Allmann; Emmanuel Tetaud; Loïc Rivière; Ariel M Silber; Michael P Barrett; Alena Zíková; Michael Boshart; Jean-Charles Portais; Frédéric Bringaud
Journal:  PLoS Pathog       Date:  2021-03-01       Impact factor: 6.823

5.  Identification and characterization of an unusual class I myosin involved in vesicle traffic in Trypanosoma brucei.

Authors:  Diana Spitznagel; John F O'Rourke; Neal Leddy; Orla Hanrahan; Derek P Nolan
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

6.  Dynamic modelling under uncertainty: the case of Trypanosoma brucei energy metabolism.

Authors:  Fiona Achcar; Eduard J Kerkhoven; Barbara M Bakker; Michael P Barrett; Rainer Breitling
Journal:  PLoS Comput Biol       Date:  2012-01-19       Impact factor: 4.475

7.  Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis.

Authors:  Juan D Unciti-Broceta; José L Arias; José Maceira; Miguel Soriano; Matilde Ortiz-González; José Hernández-Quero; Manuel Muñóz-Torres; Harry P de Koning; Stefan Magez; José A Garcia-Salcedo
Journal:  PLoS Pathog       Date:  2015-06-25       Impact factor: 6.823

8.  Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition.

Authors:  Pieter C Steketee; Emily A Dickie; James Iremonger; Kathryn Crouch; Edith Paxton; Siddharth Jayaraman; Omar A Alfituri; Georgina Awuah-Mensah; Ryan Ritchie; Achim Schnaufer; Tim Rowan; Harry P de Koning; Catarina Gadelha; Bill Wickstead; Michael P Barrett; Liam J Morrison
Journal:  PLoS Pathog       Date:  2021-07-26       Impact factor: 6.823

9.  Identification and characterization of a stage specific membrane protein involved in flagellar attachment in Trypanosoma brucei.

Authors:  Katherine Woods; Noirin Nic a'Bhaird; Clodagh Dooley; David Perez-Morga; Derek P Nolan
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: production of acetate in the mitochondrion is essential for parasite viability.

Authors:  Muriel Mazet; Pauline Morand; Marc Biran; Guillaume Bouyssou; Pierrette Courtois; Sylvie Daulouède; Yoann Millerioux; Jean-Michel Franconi; Philippe Vincendeau; Patrick Moreau; Frédéric Bringaud
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.